NEWCaplight raises a $16M Series A, led by BlackRock and Fin Capital →
Skip to main content
Caplight Logo









BIMINI Biotech

BIMINI Biotech

Private
LeidenHealthcare & Life Scienceshttps://biminibiotech.nl/

Last Round

Seed

Jan 8, 2025

Total Funding Raised

$3.89M

Company Overview

BIMINI Biotech is a preclinical stage biotechnology company developing novel first-in-class small molecule therapeutics for oncology with a focus on lymphomas and leukemia.

Sector

Healthcare & Life Sciences

Verticals

Biotechnology, Drug Discovery

Business Model

B2B

Customer Profile

Services & Consulting

AI Layer

Non-AI

Keywords

small-molecule therapeuticsdrug discoverybiotechhematological cancerWASp modulatorpreclinical developmentautoimmune diseasedrug licensingpharma partneringleukemia treatmentlymphoma treatmentfirst-in-class drugsbiopharmadrug pipelinetherapeutic startup

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

BIMINI Biotech Comparables

Compare BIMINI Biotech with similar companies based on industry and business-model similarity.

BIMINI Biotech comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
Flindr Therapeutics
76%
Dimericon Therapeutics
73%
Solu Therapeutics
69%

BIMINI Biotech Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
SeedJan 8, 2025
SeedJun 29, 2023
SeedOct 15, 2021
Pre SeedNov 26, 2020

Key People

Founding team and executive leadership

Digvijay Gahtory

Chief Executive Officer

Executive Team

Maurits van den Nieuwboer

Chief Operating Officer

Executive Team

BIMINI Biotech Investors

Notable investors and investment history

BIMINI Biotech investors
InvestorRounds
Libertatis Ergo HoldingSeed
Torrey Pines Investment LLCSeed
InnovationQuarterSeed, Pre Seed

Market signals

Structured signals derived from secondary market and firmographic data.

  • Jan 6, 2026

    Dr. Helmuth van Es joins as Independent Supervisory Board Member.

  • Jan 8, 2025

    $3.1M raised in Seed round.

BIMINI Biotech Filings

SEC and related filings with document metadata.

Data table
TypedDateAmount OfferedAmount SoldFillingPagesDownload
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation

BIMINI Biotech Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about BIMINI Biotech's valuation, stock price, and market status.

Firmographic Details

HeadquartersLeiden
Employee Range9
Year Founded2019
Last FundingJan 8, 2025

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.